AFFILIATE · REL=SPONSORED · WE DISCLOSE · HOW WE PICK

TELEHEALTH · 1:1 COMPARISON

Midi vs Alloy

Midi Health and Alloy are the two most-credentialed menopause telehealth services in the US. Both are legitimate. The right choice depends on whether you have usable insurance and whether you want a curated or a flexible formulary.

MIDI

In-network with most major insurance. Flexible prescribing across manufacturers.

Visit Midi →

ALLOY

Cash subscription, all-in pricing. Curated FDA-approved formulary.

Visit Alloy →

SIDE-BY-SIDE

Attribute Midi Alloy
Insurance Yes — most major plans in most states No — cash subscription only
Pricing Insurance copay + cash option Flat monthly subscription (meds included)
Formulary Broad — writes across manufacturers Curated FDA-approved first-line set
Clinician specialization Menopause-focused; MSCP-heavy Menopause-focused; MSCP-heavy
Prescribes testosterone Yes — for HSDD Yes — for HSDD
Prescribes pellets No No
Coverage All 50 states All 50 states

WHEN MIDI IS THE BETTER PICK

  • You have in-network insurance that covers telehealth.
  • You want flexibility across different manufacturers or dose forms.
  • You prefer live video visits over asynchronous care.

WHEN ALLOY IS THE BETTER PICK

  • You don’t have HRT-friendly insurance and want predictable monthly cost.
  • You’re comfortable with a curated formulary chosen by the medical board.
  • You want medications shipped direct rather than filling at a local pharmacy.

FREQUENTLY ASKED

Is Midi or Alloy cheaper? +

Midi is cheaper if you have in-network insurance coverage — most visits run a standard copay. Alloy is more predictable for cash-pay patients because it’s a flat monthly subscription with medications included. For patients without HRT-friendly insurance, Alloy’s all-in pricing often ends up lower than Midi’s cash rate.

Which has more menopause-specialist clinicians? +

Both lean heavily on MSCP (Menopause Society Certified Practitioner) and menopause-focused clinicians. Alloy’s medical advisory board is public and stacked with MSCP holders; Midi publishes its clinical leadership and also credentials through the Menopause Society. At the provider level they’re comparable.

Which prescribes testosterone? +

Both. Both Midi and Alloy prescribe transdermal testosterone for postmenopausal HSDD in line with the 2019 Global Consensus Statement. Neither routinely prescribes pellet testosterone, which the global consensus advises against.

Which is better for complex cases? +

Neither is ideal for genuinely complex cases — both are telehealth-only. If you have a complicated medical history, a failed previous HRT trial, or a condition that needs coordinated in-person care, a local MSCP-certified physician from this directory is a better fit than either service.

SOURCES

  1. https://www.joinmidi.com/ — pricing, state coverage, clinician profiles. Retrieved 2026-04-26.
  2. https://www.myalloy.com/ — pricing, state coverage, medical board. Retrieved 2026-04-26.
  3. Davis SR et al., Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019) — testosterone / pellet guidance.

AFFILIATE DISCLOSURE — WE MAY EARN A COMMISSION ON SIGNUPS. EDITORIAL STANCE IS INDEPENDENT OF AFFILIATE STATUS.

VERIFIED AGAINST: NPPES · ABMS · STATE BOARDS · MENOPAUSE SOCIETY · PUBMED